Wren Therapeutics is commercialising Cambridge and Lund research into therapies for protein misfolding diseases, which include Alzheimer's and motor neurone disease.

The IP Group-owned fund management unit closed three university funds targeting Cambridge, Oxford and Bristol-linked companies last year.

Adelaide's ThincLab and University of New England's SRI AgTech incubators will receive $357,000 and $229,000 of government funding respectively.

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

The Stanford University-backed fund will halt new investments from July, seemingly as the accelerator reaches financial stability but in the midst of a legal battle.

SetSquared affiliates together raised 34% more than the equivalent generated in 2017 in what was hailed as a stellar year for the program.

The respiratory disease drug developer has collected series A funding from investors including Shionogi to fund clinical trials of its lead drug candidate .

Machine tools supplier Trumpf has put funding behind Eyewear Tech to commercialise an eye tracking platform based on Idiap Research Institute and EPFL technology.

Magnitude Biosciences started operations in September 2018 to commercialise a Durham University ageing research technology centred on the C.elegans nematode worm.

The accelerator is open to medical device and healthcare tech businesses that have already amassed $500,000 of capital or are generating revenues.